AccessibilityHelp
Motus Gi logo

Motus Gi(OTC) MOTS

Market Cap$1.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-100%
5 Year-100%
1 Year+100%
1 Month+19,900%
$0.00
+0.00%
+0.00Today
Motus Gi last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-21
Motus Gi stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-10-14
1 month+19,900%USD 0.002026-09-21
3 month+19,900%USD 0.002026-07-22
Year to date+100%USD 0.002025-12-31
1 year+100%USD 0.002025-10-21
3 year-100%USD 7.202023-10-20
5 year-100%USD 182.972021-10-22
Since inception-100%USD 1,314.002018-02-14

Motus Gi Financials at a Glance

Market Cap

$1.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$327.00K

Net Income (TTM)

-$10.59M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-29.29 (Low)

Price

$0.00

Volume

1

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

Estimated Earnings Date

Aug 31, 2026

MOTS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Motus Gi

Motus GI Holdings, Inc. is a medical technology company focused on developing innovative solutions for gastrointestinal procedures. The company is known for its Pure-Vu system, which enhances the cleansing of poorly prepared gastrointestinal tracts during colonoscopy and upper gastrointestinal endoscopy procedures.

Products and Services
  • Pure-Vu system for gastrointestinal tract cleansing
  • Innovative medical devices for endoscopic procedures
  • Research and development in gastrointestinal technologies
Growth Outlook
  • Increasing demand for gastrointestinal procedures drives market potential
  • Focus on expanding product offerings to enhance procedural efficiency
  • Strategic partnerships may enhance market penetration and growth
Financial Highlights
  • Q1 2024 revenue of $64,000, consistent with previous quarter
  • Net income for Q1 2024 was -$2,113,000, reflecting ongoing investment in R&D
  • Cash and cash equivalents at $4,944,000, providing operational liquidity
Motus GI Holdings, Inc. operates in the healthcare sector, specifically within the medical devices industry. The company's flagship product, the Pure-Vu system, addresses a critical need in gastrointestinal procedures, potentially improving patient outcomes and procedural efficiency. The growth outlook remains positive, driven by increasing demand for gastrointestinal interventions and the company's commitment to innovation. Recent financial data indicates a stable revenue stream, although the company continues to operate at a loss as it invests heavily in research and development. The cash reserves provide a buffer for ongoing operations and future growth initiatives. Overall, Motus GI Holdings, Inc. presents an intriguing opportunity for investors interested in the medical technology space.
AI Generated • Oct 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

15

CEO

Mark Pomeranz

Website

www.motusgi.com

Headquarters

Fort Lauderdale, FL 33301, US

MOTS Financials

Key Financial Metrics (TTM)

Gross Margin

-78.37%

Operating Margin

-3732.60%

Net Income Margin

-4033.54%

Return on Equity

-454.34%

Return on Capital

-230.98%

Return on Assets

-178.14%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

6.39M

Volume

1

Avg. Volume

626.323

Financials (TTM)

Gross Profit

-$160.00K

Operating Income

-$9.57M

EBITDA

-$9.36M

Operating Cash Flow

-$8.62M

Capital Expenditure

-$65.00K

Free Cash Flow

-$8.68M

Cash & ST Invst.

$4.94M

Total Debt

$2.44M

Motus Gi Performance Analysis

Motus Gi annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 391,000N/A
20222022-12-31USD 592,00051.4%
20232023-12-31USD 319,000-46.1%
Motus Gi sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22023-06-30101.8%
Q32023-09-30-23.9%
Q42023-12-31-25.6%
Q12024-03-31N/A
Motus Gi annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -161.07N/A
20222022-12-31USD -86.15-46.5%
20232023-12-31USD -15.89-81.6%
Motus Gi sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22023-06-3056.9%
Q32023-09-3028.1%
Q42023-12-3157.7%
Q12024-03-3151.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2024YOY CHG

Revenue

$64.00K

+14.3%

Gross Profit

$52.00K

+144.1%

Gross Margin

81.25%

N/A

Market Cap

$1.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$86.67

N/A

Employees

15

N/A

Net Income

-$2.11M

+51.8%

EBITDA

-$1.88M

+52.4%

Quarterly Fundamentals

Name
Q1 2024YOY CHG

Total Cash

$4.94M

-42.8%

Total Debt

$2.44M

-77.4%

Accounts Receivable

$81.00K

+55.8%

Inventory

$228.00K

-50.9%

Long Term Debt

$690.00K

-91.3%

Short Term Debt

$1.75M

-38.9%

Return on Assets

-1.78%

N/A

Return on Invested Capital

-3.01%

N/A

Free Cash Flow

-$2.02M

+58.2%

Operating Cash Flow

-$2.02M

+57.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BIIOBionovate Technologies Corp
$0.00+0.00%
ATRXAdhera Therapeutics Inc
$0.00+0.00%
CNNXFCannAmerica Brands Corp.
$0.00+0.00%
ROSGQRosetta Genomics Ltd.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$7.88-14.87%
SPCXSpace Exploration Technologies
$145.12-8.91%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$82.80-19.80%
INTCIntel
$85.94-7.55%

Questions About MOTS

What is the current price of Motus Gi?

Motus Gi is trading at $0.00 per share.

What is the 52-week range for Motus Gi?

Over the past 52 weeks, Motus Gi has traded between $0.00 and $0.10.

How much debt does Motus Gi have?

As of the most recent reporting period, Motus Gi reported total debt of $2.47M.

How much cash does Motus Gi have on hand?

Motus Gi reported $4.96M in cash and cash equivalents in its most recent financial results.

What is Motus Gi’s dividend yield?

Motus Gi does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services